SEARCH

SEARCH BY CITATION

References

  • 1
    Sundfeldt M, Carlsson LV, Johansson CB, Thomsen P & Gretzer C (2006) Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop 77, 177197.
  • 2
    Abu-Amer Y, Darwech I & Clohisy JC (2007) Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies. Arthritis Res Ther 9 (Suppl. 1), S6.
  • 3
    Takagi M (1996) Neutral proteinases and their inhibitors in the loosening of total hip prostheses. Acta Orthop Scand Suppl 271, 329.
  • 4
    Takei I, Takagi M, Santavirta S, Ida H, Hamasaki M, Ishii M, Fukushima S, Ogino T & Konttinen YT (1999) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints. J Biomed Mater Res 45, 175183.
  • 5
    Syggelos SA, Eleftheriou SC, Giannopoulou E, Panagiotopoulos E & Aletras AJ (2001) Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses. J Rheumatol 28, 13191329.
  • 6
    Nagase H, Visse R & Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69, 562573.
  • 7
    Gialeli C, Theocharis AD & Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278, 1627.
  • 8
    Knäuper V & Murphy G (1998) Membrane type-matrix metalloproteinases and cell surface-assiciated activation cascade for matrix metalloproteinases. In Matrix Metalloproteinases (Parks WC & Mecham RP, eds.), pp 199218. Academic Press, Harcourt Brace & Company, Publishers, San Diego, London, Boston, New York, Sydney, Toronto.
  • 9
    Polette M & Birembaut P (1998) Membrane-type metalloproteinases in tumor invasion. Int J Biochem Cell Biol 30, 11951202.
  • 10
    Hernandez-Barrantes S, Bernardo M, Toth M & Fridman R (2002) Regulation of membrane type-matrix metalloproteinases. Semin Cancer Biol 12, 131138.
  • 11
    Sounni NE & Noel A (2005) Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87, 329342.
  • 12
    Yana I & Weiss SJ (2000) Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 11, 23872401.
  • 13
    Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d'Ortho MP & Murphy G (1998) The TIMP2 membrane type 1 metalloproteinase ‘receptor’ regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 273, 871880.
  • 14
    Morgunova E, Tuuttila A, Bergmann U & Tryggvason K (2002) Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc Natl Acad Sci USA 99, 74147419.
  • 15
    Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Sang QA & Fridman R (2000) Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and proMMP-2 activation. J Biol Chem 275, 1208012089.
  • 16
    Bernardo MM & Fridman R (2003) TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after proMMP-2 activation by MT1 (membrane type 1)-MMP. Biochem J 374, 739745.
  • 17
    Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S & Fridman R (2003) ProMMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochem Biophys Res Commun 308, 386395.
  • 18
    Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M & Okada Y (1997) Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272, 24462451.
  • 19
    Barbolina MV & Stack MS (2008) Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. Semin Cell Dev Biol 19, 2433.
  • 20
    Will H, Atkinson SJ, Butler GS, Smith B & Murphy G (1996) The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 271, 1711917123.
  • 21
    Kazes I, Delarue F, Hagège J, Bouzhir-Sima L, Rondeau E, Sraer JD & Nguyen G (1998) Soluble latent membrane-type 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinase. Kidney Int 54, 19761984.
  • 22
    Li H, Bauzon DE, Xu X, Tschesche H, Cao J & Sang QA (1998) Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. Mol Carcinog 22, 8494.
  • 23
    Lohi J, Lehti K, Westermarck J, Kähäri VM & Keski-Oja J (1996) Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 239, 239247.
  • 24
    Okumura Y, Sato H, Seiki M & Kido H (1997) Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin: a possible cell surface activator. FEBS Lett 402, 181184.
  • 25
    Toth M, Hernandez-Barrantes S, Osenkowski P, Bernardo MM, Gervasi DC, Shimura Y, Meroueh O, Kotra LP, Galvez BG, Arroyo AG et al. (2002) Complex pattern of membrane type-1 matrix metalloproteinase shedding. Regulation by autocatalytic cell surface inactivation of active enzyme. J Biol Chem 277, 2634026350.
  • 26
    Toth M, Osenkowski P, Hesek D, Brown S, Meroueh S, Sakr W, Mobashery S & Fridman R (2005) Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase. Biochem J 387, 497506.
  • 27
    Harayama T, Ohuchi E, Aoki T, Sato H, Seiki M & Okada Y (1999) Shedding of membrane type 1 matrix metalloproteinase in a human breast carcinoma cell line. Jpn J Cancer Res 90, 942950.
  • 28
    Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AJ & Cao J (1998) Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273, 12161222.
  • 29
    Galvez BG, Matias-Roman S, Albar JP, Sanchez-Madrid F & Arroyo AG (2001) Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J Biol Chem 276, 3749137500.
  • 30
    Maisi P, Prikk K, Sepper R, Pirila E, Salo T, Hietanen J & Sorsa T (2002) Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS 110, 771782.
  • 31
    Itoh Y, Binner S & Nagase H (1995) Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem J 308, 645651.
  • 32
    Migita K, Eguchi K, Kawabe Y, Ichinose Y, Tsukada T, Aoyagi T, Nakamura H & Nagataki S (1996) TNF-α-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology 89, 553557.
  • 33
    Büttner FH, Chubinskaya S, Margerie D, Huch K, Flechtenmacher J, Cole AA & Bartnik E (1997) Expression of membrane type 1 matrix metalloproteinase in human articular cartilage. Arthritis Rheum 40, 704709.
  • 34
    Imai K, Ohta S, Matsumoto T, Fujimoto N, Sato H, Seiki M & Okada Y (1997) Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol 151, 245256.
  • 35
    Yamanaka H, Makino K, Takizawa M, Nakamura H, Fujimoto N, Moriya H, Nemori R, Sato H, Seiki M & Okada Y (2000) Expression of tissue localization of mambrane-types 1, 2 and 3 matrix metalloproteinases in rheumatoid synovium. Lab Invest 80, 677687.
  • 36
    Honda S, Migita K, Hirai Y, Origuchi T, Yamasaki S, Kamachi M, Shibatomi K, Fukuda T, Kita M, Hida A et al. (2001) Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cells. Clin Exp Immunol 126, 131136.
  • 37
    Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M & Okada Y (1999) Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol 154, 417428.
  • 38
    Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M & Okada Y (1999) Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res 59, 467473.
  • 39
    Tsunezuka Y, Kinoh H, Takino T, Watanabe Y & Okada Y (1996) Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay. Cancer Res 56, 56785683.
  • 40
    Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M & Okada Y (1997) Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 57, 20552060.
  • 41
    Simiantonaki N, Jayasinghe C & Kirkpatrick CJ (2002) Differential endothelial CAM-expression after stimulation with supernatants of LPS- and cytokine-stimulated HT-29 and ST-ML-12 tumor cells growing as monolayer cultures and multicellular spheroids. Anticancer Res 22, 26412649.
  • 42
    Yu M, Sato H, Seiki M & Thompson EW (1995) Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancel cells. Cancer Res 55, 32723277.
  • 43
    Sato T, del Carmen Ovejero M, Hou P, Heegaard AM, Kumegawa M, Foged NT & Delaissé JM (1997) Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J Cell Sci 110, 589596.
  • 44
    Nguyen M, Arkell J & Jackson CJ (2000) Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP. Int J Biochem Cell Biol 32, 621631.
  • 45
    Takino T, Sato H, Yamamoto E & Seiki M (1995) Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain. Gene 155, 293298.
  • 46
    Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M & Okada Y (1996) Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 56, 27072710.
  • 47
    Okada A, Bellocq J-P, Rouyer N, Chenard M-P, Rio M-C, Chambon P & Basset P (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92, 27302734.
  • 48
    Lehti K, Lohi J, Valtanen H & Keski-Oja J (1998) Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J 334, 345353.
  • 49
    Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA & Goldberg GI (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270, 53315338.
  • 50
    Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E & Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 6165.
  • 51
    Cao J, Drews M, Lee HM, Conner C, Bahou WF & Zucker S (1998) The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activa-tion of pro-gelatinase A. J Biol Chem 273, 3474534752.
  • 52
    Cao J, Hymowitz M, Conner C, Bahou WF & Zucker S (2000) The propeptide domain of membrane type 1-matrix metalloproteinase acts as an intramolecular chaperone when expressed in trans with the mature sequence in COS-1 cells. J Biol Chem 275, 2964829653.
  • 53
    Pavlaki M, Cao J, Hymowitz H, Chen WT, Bahou W & Zucker SA (2002) Conserved sequence within the propeptide domain of membrane type 1 matrix metalloproteinase is critical for function as an intramolecular chaperone. J Biol Chem 277, 27402749.
  • 54
    Ogata Y, Itoh Y & Nagase H (1995) Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J Biol Chem 270, 1850618511.
  • 55
    Goldberg GI, Strongin A, Collier IE, Genrich T & Marmer BL (1992) Interaction of 92 kDa type IV collagenase with the tissue inhibitor of metallopro-teinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 267, 45834591.
  • 56
    Pawliczak R, Lewandowska-Polak A & Kowalski ML (2005) Pathogenesis of nasal polyps: an update. Curr Allergy Asthm R5, 463471.
  • 57
    Firestein GS, Yeo M & Zvaifler NJ (1995) Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96, 16311638.
  • 58
    Pavlaki M, Giannopoulou E, Niarakis A, Ravazoula P & Aletras AJ (2009) Walker 256 cancer cells secrete tissue inhibitor of metalloproteinase-free metalloproteinase-9. Mol Cell Biochem 328, 189199.
  • 59
    Sato T, Ito A & Mori Y (1990) Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. Biochem Biophys Res Commun 170, 824829.
  • 60
    Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680685.
  • 61
    Moore BA, Aznavoorian S, Engler JA & Windsor LJ (2000) Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. Biochim Biophys Acta 1502, 307318.
  • 62
    Hsu SM, Raine L & Fanger H (1981) Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29, 577580.
  • 63
    Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248254.